Status:
UNKNOWN
Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
20-80 years
Brief Summary
In malignant or neoplastic disease, angiogenesis is defined as the generation of new capillaries from preexisting blood vessels, e.g. by sprouting or by intusseption. Through the pioneering work of Fo...
Detailed Description
In malignant or neoplastic disease, angiogenesis is defined as the generation of new capillaries from preexisting blood vessels, e.g. by sprouting or by intusseption. Through the pioneering work of Fo...
Eligibility Criteria
Inclusion
- Acute myeloid leukemia (AML) patients with intention to receive induction chemotherapy
- Dynamic contrast-enhanced magnetic resonance imaging (dMRI) performed before, during and after complete course of induction chemotherapy
- Age and sex matched normal volunteers
Exclusion
- AML patients with palliative chemotherapy only
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00172562
Last Update
March 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tiffany Ting-Fang Shih
Taipei, Taiwan